Researchers have developed a molecule called SU212 that could revolutionize treatment for triple-negative breast cancer, one of the most aggressive and difficult-to-treat forms of the disease.
Boeing Co. said it will ensure its factories are ready to absorb a higher rate of aircraft output before lifting the tempo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback